Delivery Order SPE2DB20D3103-SPE2DB24FQ0P3
Award Date
8/27/24
Potential Completion Date
8/28/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,832.06, is for the delivery of 4567984776 DEXTROAMP-AMPHET ER 20 MG CAP 100S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,601.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567136727 DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product, and has an ultimate completion date of February 4, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not associated with a set-aside designation,...
This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTLD6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,049.08 firm fixed-price delivery order is for the supply of 4568038450 - DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product. The award is not set-aside and has an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FB8Y1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4568004519 - DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product. The contract has a firm fixed price of $2,721.62 and an ultimate completion date of April 24, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp...
This federal contract award, with ID SPE2DB24D2208|SPE2DB25FHHPT, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order with a firm fixed price for the supply of 4,568,120,543 units of the pharmaceutical product DEXTROAMP-AMPHET ER 20 MG CAP 100S. The award has a ceiling value of $1,757.94 and an ultimate completion date of May 5, 2025. The contract is not set aside and was open for competition. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,143.22. The contract provides for the delivery of DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product, with a performance period through June 30, 2025. The contract is not designated as a set-aside....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,163.56 with a Firm Fixed Price pricing type. It provides for the delivery of 4568567882 - DEXTROAMP-AMPHET ER 20 MG CAP 100S, a prescription medication, with a performance period ending on June 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug...
This federal contract award, with the ID SPE2DB22D2006|SPE2DB24FV6CR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,091.80, is for the delivery of 4562777696 ! DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product. This is a Firm Fixed Price delivery order contract, with a completion date of November 13, 2023. The contract does not have a set-aside...
This federal contract award, valued at $1,722.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567458315 DEXTROAMP-AMPHET ER 10 MG CAP 100S, a pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of March 5, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp...
This federal contract award, valued at $1,190.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB24D2100|SPE2DB25FBDRN) for the supply of 4567967859 DEXTROAMP-AMPHET ER 20 MG CAP 100S, with a firm fixed price and an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...